{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:40:20Z","timestamp":1777455620587,"version":"3.51.4"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.breast.2017.06.032","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T19:30:13Z","timestamp":1498591813000},"page":"S70-S77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"S1","title":["Age, molecular subtypes and local therapy decision-making"],"prefix":"10.1016","volume":"34","author":[{"given":"Anne","family":"Kuijer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tari A.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2017.06.032_bib1","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/jnci\/djt134","article-title":"Prospective observational study of breast cancer treatment outcomes for UK women aged 18\u201340 years at diagnosis: the POSH study","volume":"105","author":"Copson","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2017.06.032_bib2","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s10549-011-1872-9","article-title":"Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer","volume":"131","author":"Collins","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2017.06.032_bib3","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1634\/theoncologist.2014-0184","article-title":"Age-specific changes in intrinsic breast cancer subtypes: a focus on older women","volume":"19","author":"Jenkins","year":"2014","journal-title":"Oncologist"},{"key":"10.1016\/j.breast.2017.06.032_bib4","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1056\/NEJMoa021967","article-title":"A\u00a0gene-expression signature as a predictor of survival in breast cancer","volume":"347","author":"van de Vijver","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.breast.2017.06.032_bib5","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","article-title":"Race, breast cancer subtypes, and survival in the Carolina breast cancer study","volume":"295","author":"Carey","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.breast.2017.06.032_bib6","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/annonc\/mdq072","article-title":"Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer","volume":"21","author":"Cancello","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2017.06.032_bib7","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1016\/j.ejca.2013.05.030","article-title":"Local recurrence following breast-conserving treatment in women aged 40 years or younger: trends in risk and the impact on prognosis in a population-based cohort of 1143 patients","volume":"49","author":"van Laar","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2017.06.032_bib8","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1200\/JCO.2015.64.3536","article-title":"Contemporary locoregional recurrence rates in young patients with early-stage breast cancer","volume":"34","author":"Aalders","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2017.06.032_bib9","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1200\/JCO.2011.36.1105","article-title":"Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy","volume":"29","author":"Arvold","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2017.06.032_bib10","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1200\/JCO.2006.10.3754","article-title":"Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea\u2013a report from the Korean Breast Cancer Society","volume":"25","author":"Ahn","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2017.06.032_bib11","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1007\/s00268-011-1071-1","article-title":"Prognostic significance of young age (<35 years) by subtype based on ER, PR, and HER2 status in breast cancer: a nationwide registry-based study","volume":"35","author":"Kim","year":"2011","journal-title":"World J Surg"},{"key":"10.1016\/j.breast.2017.06.032_bib12","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1245\/s10434-016-5631-3","article-title":"Evaluation of local and distant recurrence patterns in patients with triple-negative breast cancer according to age","volume":"24","author":"Radosa","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2017.06.032_bib13","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10549-014-3125-1","article-title":"Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time?","volume":"147","author":"Sheridan","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2017.06.032_bib14","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1200\/JCO.2015.65.8013","article-title":"Subtype-dependent relationship between young age at diagnosis and breast cancer survival","volume":"34","author":"Partridge","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2017.06.032_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10549-016-4031-5","article-title":"Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapy","volume":"161","author":"Braunstein","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2017.06.032_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijrobp.2013.09.024","article-title":"Is biological subtype prognostic of locoregional recurrence risk in women with pT1-2N0 breast cancer treated with mastectomy?","volume":"88","author":"Truong","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2017.06.032_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/jso.23604","article-title":"Age and molecular subtypes: impact on surgical decisions","volume":"110","author":"Pilewskie","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.breast.2017.06.032_bib18","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.ijrobp.2006.11.032","article-title":"Is mastectomy superior to breast-conserving treatment for young women?","volume":"67","author":"Coulombe","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2017.06.032_bib19","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ijrobp.2014.06.041","article-title":"Should women younger than 40 years of age with invasive breast cancer have a mastectomy? 15-year outcomes in a population-based cohort","volume":"90","author":"Cao","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2017.06.032_bib20","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/cncr.20022","article-title":"Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma","volume":"100","author":"Kroman","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2017.06.032_bib21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10549-010-1110-x","article-title":"Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged <\/= 40 years","volume":"127","author":"van der Sangen","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2017.06.032_bib22","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.ijrobp.2011.10.075","article-title":"Similar survival with breast conservation therapy or mastectomy in the management of young women with early-stage breast cancer","volume":"83","author":"Mahmood","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2017.06.032_bib23","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1016\/j.ijrobp.2011.02.060","article-title":"Early-stage young breast cancer patients: impact of local treatment on survival","volume":"81","author":"Bantema-Joppe","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2017.06.032_bib24","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.ijrobp.2015.08.044","article-title":"In the modern treatment era, is breast conservation equivalent to mastectomy in women younger than 40 years of age? A multi-institution study","volume":"93","author":"Frandsen","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2017.06.032_bib25","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.clbc.2015.03.012","article-title":"Equivalent survival with mastectomy or breast-conserving surgery plus radiation in young women aged < 40 years with early-stage breast cancer: a national registry-based stage-by-stage comparison","volume":"15","author":"Ye","year":"2015","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.breast.2017.06.032_bib26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/SLA.0000000000001930","article-title":"Local recurrence and breast oncological surgery in young women with breast cancer: the POSH observational cohort study","volume":"266","author":"Maishman","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.breast.2017.06.032_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.breast.2015.02.002","article-title":"Overall survival according to type of surgery in young (<\/=40 years) early breast cancer patients: a systematic meta-analysis comparing breast-conserving surgery versus mastectomy","volume":"24","author":"Vila","year":"2015","journal-title":"Breast"},{"key":"10.1016\/j.breast.2017.06.032_bib28","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1016\/j.clbc.2016.11.007","article-title":"Molecular subtypes and prognosis in young mexican women with breast cancer","volume":"17","author":"Villarreal-Garza","year":"2017","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.breast.2017.06.032_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10549-016-3983-9","article-title":"Long-term outcome in young women with breast cancer: a population-based study","volume":"160","author":"Fredholm","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2017.06.032_bib30","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1200\/JCO.2003.07.071","article-title":"Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer","volume":"21","author":"Partridge","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2017.06.032_bib31","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1200\/JCO.2006.07.2793","article-title":"Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer","volume":"24","author":"Walshe","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2017.06.032_bib32","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1158\/1078-0432.CCR-11-2599","article-title":"Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling","volume":"18","author":"Azim","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.breast.2017.06.032_bib33","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/jamasurg.2013.3037","article-title":"Breast-conserving therapy for triple-negative breast cancer","volume":"149","author":"Gangi","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1016\/j.breast.2017.06.032_bib34","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1200\/JCO.2010.29.4041","article-title":"Clinical management factors contribute to the decision for contralateral prophylactic mastectomy","volume":"29","author":"King","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2017.06.032_bib35","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1245\/s10434-010-1136-7","article-title":"Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer","volume":"17","author":"Boughey","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2017.06.032_bib36","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0002-9610(00)00505-5","article-title":"Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer","volume":"180","author":"Peralta","year":"2000","journal-title":"Am J Surg"},{"key":"10.1016\/j.breast.2017.06.032_bib37","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/jnci\/djq018","article-title":"Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients","volume":"102","author":"Bedrosian","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2017.06.032_bib38","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1245\/s10434-014-3956-3","article-title":"Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer","volume":"21","author":"Pesce","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2017.06.032_bib39","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1200\/JCO.2010.32.7395","article-title":"Declining incidence of contralateral breast cancer in the United States from 1975 to 2006","volume":"29","author":"Nichols","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2017.06.032_bib40","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10549-010-1137-z","article-title":"Risk of second breast cancer according to estrogen receptor status and family history","volume":"127","author":"Bouchardy","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2017.06.032_bib41","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/s13058-014-0452-4","article-title":"Risk of contralateral second primary breast cancer according to hormone receptor status in Germany","volume":"16","author":"Rusner","year":"2014","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.breast.2017.06.032_bib42","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.4143\/crt.2015.456","article-title":"Locoregional recurrence by tumor biology in breast cancer patients after preoperative chemotherapy and breast conservation treatment","volume":"48","author":"Jwa","year":"2016","journal-title":"Cancer Res Treat"},{"issue":"22 Suppl.","key":"10.1016\/j.breast.2017.06.032_bib43","doi-asserted-by":"crossref","first-page":"S495","DOI":"10.1245\/s10434-015-4697-7","article-title":"The effect of molecular subtype and residual disease on locoregional recurrence in breast cancer patients treated with neoadjuvant chemotherapy and postmastectomy radiation","volume":"3","author":"Yang","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2017.06.032_bib44","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1186\/bcr3198","article-title":"Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy","volume":"14","author":"Caudle","year":"2012","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.breast.2017.06.032_bib45","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1245\/s10434-015-4921-5","article-title":"Locoregional control according to breast cancer subtype and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast-conserving therapy","volume":"23","author":"Swisher","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2017.06.032_bib46","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1016\/S1470-2045(11)70383-7","article-title":"Management of elderly patients with breast cancer: updated recommendations of the international society of geriatric oncology (SIOG) and European society of breast cancer specialists (EUSOMA)","volume":"13","author":"Biganzoli","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2017.06.032_bib47","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/jnci\/djr257","article-title":"Incidence of breast cancer in the United States: current and future trends","volume":"103","author":"Anderson","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2017.06.032_bib48","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10549-011-1451-0","article-title":"Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in The Netherlands","volume":"129","author":"de Munck","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2017.06.032_bib49","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/07357907.2016.1182184","article-title":"Breast cancer subtypes in patients aged 70 years and older","volume":"34","author":"Konigsberg","year":"2016","journal-title":"Cancer Invest"},{"key":"10.1016\/j.breast.2017.06.032_bib50","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.2009.25.9796","article-title":"Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival","volume":"28","author":"Schonberg","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2017.06.032_bib51","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1200\/JCO.2008.16.7619","article-title":"Relationship between age and axillary lymph node involvement in women with breast cancer","volume":"27","author":"Wildiers","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2017.06.032_bib52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.breast.2016.08.004","article-title":"Low risk of recurrence in elderly patients treated with breast conserving therapy in a single institute","volume":"30","author":"van der Leij","year":"2016","journal-title":"Breast"},{"key":"10.1016\/j.breast.2017.06.032_bib53","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343","volume":"31","author":"Hughes","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2017.06.032_bib54","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1470-2045(14)71221-5","article-title":"Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial","volume":"16","author":"Kunkler","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2017.06.032_bib55","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1245\/s10434-013-3374-y","article-title":"Breast-conserving surgery with or without radiotherapy in older breast patients with early stage breast cancer: a systematic review and meta-analysis","volume":"21","author":"van de Water","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2017.06.032_bib56","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials","volume":"378","author":"Darby","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2017.06.032_bib57","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ijrobp.2006.12.045","article-title":"Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer","volume":"68","author":"Potter","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2017.06.032_bib58","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.clbc.2016.06.017","article-title":"Adjuvant radiation improves survival in older women following breast-conserving surgery for estrogen receptor-negative breast cancer","volume":"16","author":"Daugherty","year":"2016","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.breast.2017.06.032_bib59","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.breast.2017.06.032_bib60","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"Giuliano","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.breast.2017.06.032_bib61","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/SLA.0b013e31827660a8","article-title":"Axillary dissection versus no axillary dissection in older patients with T1N0 breast cancer: 15-year results of a randomized controlled trial","volume":"256","author":"Martelli","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.breast.2017.06.032_bib62","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1200\/JCO.2005.01.5784","article-title":"Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93","volume":"24","author":"Rudenstam","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2017.06.032_bib63","unstructured":"Choosing Wisely: An initiative of the ABIM Foundation. http:\/\/www.choosingwisely.org. [Accessed 25 January 2017]."},{"key":"10.1016\/j.breast.2017.06.032_bib64","unstructured":"The Society of Surgical Oncology Encourages Doctors, Patients to Question Specific Commonly-used Tests and Treatments as part of choosing wisely campaign. https:\/\/www.surgonc.org\/news-publications\/for-the-press\/2016\/07\/12\/the-society-of-surgical-oncology-encourages-doctors-patients-to-question-specific-commonly-used-tests-and-treatments-as-part-of-choosing-wisely-campaign. [Accessed January 25 2017]."},{"key":"10.1016\/j.breast.2017.06.032_bib65","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/cncr.24174","article-title":"Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients: a systematic review and meta-analysis","volume":"115","author":"Sanghani","year":"2009","journal-title":"Cancer"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977617305040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977617305040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:39:10Z","timestamp":1760776750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977617305040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":65,"alternative-id":["S0960977617305040"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2017.06.032","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age, molecular subtypes and local therapy decision-making","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2017.06.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}